Research Topics
Genomes and GenesSpecies | Raimon SanmartiSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathyJosé A Gómez-Puerta
Department of Rheumatology, Hospital Clinic, Barcelona, Spain
Clin Rheumatol 28:95-7. 2009..The patient was treated with mycophenolate mofetil (1.5 g/day) with a significant improvement in proteinuria...- Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup studyRaimon Sanmarti
Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, Barcelona, Spain
J Rheumatol 39:1929-33. 2012..To analyze longterm progression to rheumatoid arthritis (RA) and the predictive value of anticitrullinated peptide/protein antibodies (ACPA) in palindromic rheumatism (PR)... - [Biomarkers in rheumatoid arthritis]Raimon Sanmarti
Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
Reumatol Clin 6:S25-8. 2011..have been studied. The present article reviews research only on soluble biomarkers, mainly those in serum, related to the diagnosis and joint destruction in RA... 
Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical settingR Sanmarti
Hospital Clinic, Rheumatology, Barcelona, Spain
Rheumatology (Oxford) 42:1044-9. 2003..To analyse the frequency and prognostic factors of radiographic progression in a series of Spanish patients with early rheumatoid arthritis (RA) after 1 yr of treatment with disease-modifying anti-rheumatic drugs (DMARDs)...
Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritisRaimon Sanmarti
Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain
Arthritis Res Ther 11:R135. 2009....- Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoidsR Sanmarti
Arthritis Unit, Rheumatology Service, IDIBAPS, Hospital Clinic of Barcelona, Villarroel 170, Barcelona 08036, Spain
Clin Rheumatol 26:1111-8. 2007..The utility of these parameters in clinical practice is limited by their relatively low positive predictive value... - Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trialR Sanmarti
Hospital Clinic, IDIBAPS, Rheumatology, Barcelona, Spain
Rheumatology (Oxford) 44:1140-4. 2005..To assess the efficacy and safety of adsorptive granulocyte and monocyte apheresis (GCAP) in patients with refractory rheumatoid arthritis (RA)... - [Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab]Raimon Sanmarti
Unidad de Artritis, Servicio de Reumatologia, IDIBAPS, Hospital Clinic de Barcelona, Spain
Med Clin (Barc) 122:321-4. 2004..The aim of this study was to evaluate the efficacy and safety of etanercept in patients with RA, who had previously failed to infliximab... - Palindromic rheumatism and other relapsing arthritisRaimon Sanmarti
Arthritis Unit, Rheumatology Service, Hospital Clinic de Barcelona, Villarroel 170, Barcelona 08036, Spain
Best Pract Res Clin Rheumatol 18:647-61. 2004..In this chapter, we discuss recent developments in these diseases with special emphasis on palindromic rheumatism, a common condition whose close relationship with rheumatoid arthritis remains intriguing... - Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritisJavier Narvaez
Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, Barcelona, Spain
Semin Arthritis Rheum 41:401-5. 2011.... - Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritisConcepción Moll
Unitat d Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, 08036, Barcelona, Spain
Clin Rheumatol 28:1053-7. 2009..This exploratory study shows some distinctive features between BD and PsA knee synovitis that confirm macroscopic differences in patients with previously reported immunopathological differences... - Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritisVirginia Ruiz-Esquide
Arthritis Unit, Rheumatology Service, IDIBAPS, Hospital Clinic, Barcelona, Spain
J Rheumatol 38:2536-9. 2011..To analyze the effects of cigarette smoking on disease activity and radiographic damage in patients with early rheumatoid arthritis (RA)... - Distinct synovial immunopathology in Behçet disease and psoriatic arthritisJuan D Canete
Arthritis Unit, Department of Rheumatology, Hospital Clinic de Barcelona and IDIBAPS, Villaroel 170, Barcelona 08036, Spain
Arthritis Res Ther 11:R17. 2009..The aim of the study was to investigate synovial immunopathology differences between early Behçet disease (BD) and psoriatic arthritis (PsA)... - Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 casesJuan D Canete
Rheumatology Department, Institut Clínic de l Aparell Locomotor ICAL, Hospital Clinic de Barcelona, and Institut d Investigacions Biomédiques Agustí Pí i Suñer IDIBAPS, Universitat de Barcelona, Barcelona, Spain
Semin Arthritis Rheum 32:378-87. 2003.... - Association of intermittent hydrarthrosis with MEFV gene mutationsJuan D Canete
Hospital Clinic, Barcelona, Spain
Arthritis Rheum 54:2334-5. 2006 - Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapyElena Izquierdo
Servicio de Reumatologia, Hospital 12 de Octubre, Madrid, Spain
Arthritis Rheum 63:2575-83. 2011..This study was undertaken to evaluate the fibroblast-specific marker Hsp47 as a quantitative marker for SFs and to analyze its clinicopathologic correlates and evolution after anti-tumor necrosis factor α (anti-TNFα) therapy... - The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritisMorteza Malakoutikhah
Department of Biomedical Chemistry, IQAC CSIC, Jordi Girona 18 26, Barcelona, Spain
J Med Chem 54:7486-92. 2011..Each of the target molecules reported here (fibrin, vimentin, filaggrin) has a specific utility in the identification of a particular subset of RA patients... - Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapyElena Izquierdo
Servicio de Reumatologia, Hospital 12 de Octubre, Madrid, Spain
PLoS ONE 4:e8131. 2009..We searched for the presence of immature vessels in RA synovium and analyzed the dynamics of synovial vasculature along the course of the disease, particularly after therapeutic response to TNF antagonists... - Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literatureConcepción Moll
Arthritis Unit, Rheumatology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain
Semin Arthritis Rheum 37:299-306. 2008..We describe 2 new cases with ilium osteitis as the main SAPHO syndrome feature and review reported cases treated with anti-TNF-alpha... - Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature reviewLaia Gifre
Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Spain
Arch Bronconeumol 47:208-12. 2011..Potential pathogenic mechanisms of the paradoxical effect of anti-TNF treatment is discussed. It is important for clinicians to be aware of this potential and uncommon complication of biological therapy with TNF antagonists... - Ectopic lymphoid neogenesis in psoriatic arthritisJuan D Canete
Servicio de Reumatologia, Hospital 12 de Octubre, 28041 Madrid, Spain
Ann Rheum Dis 66:720-6. 2007..This process involves the expression of specific homing chemokines and the development of high endothelial venules (HEV)... - An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatismJuan D Canete
Institut d Investigacions Biomediques August Pi i Sunyer, and Servei de Reumatologia, Hospital Clinic de Barcelona, Villaroel 170, 08036 Barcelona, Spain
Arthritis Rheum 56:2784-8. 2007.... - Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDsJavier Narvaez
Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
Clin Exp Rheumatol 29:991-7. 2011.... - Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?Virginia Ruiz-Esquide
Rheumatology Service, Hospital Clinic, Barcelona, Spain
Clin Rheumatol 31:1047-50. 2012..The prevalence of ACPA in heavy smokers without RA is low, but seems to be higher in heavy smokers with COPD. Larger studies are necessary to confirm these findings and determine the relationship between ACPA and lung disease... - Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort studyJuan D Canete
Rheumatology Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain
Rheumatology (Oxford) 50:721-8. 2011.... - Morphea associated with the use of adalimumab: a case report and review of the literatureJulio Ramirez
Arthritis Unit, Department of Rheumatology, Hospital Clinic, University of Barcelona, Villarroel 170, Stairway 11, 2nd Floor, 08036, Barcelona, Spain
Mod Rheumatol 22:602-4. 2012..Adalimumab was discontinued, which resulted in progressive improvement in the skin lesions, with only mild hyperpigmentation remaining. We also review reports of morphea and other adverse cutaneous events related to anti-TNF treatment... - Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical featuresRaquel Celis
Arthritis Unit, Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, C Villarroel, 170, 08036 Barcelona, Spain
Arthritis Res Ther 14:R93. 2012..We determined whether LN is associated with specific patterns of inflammatory cytokine expression in paired synovial tissue (ST) and fluid (SF) samples and their potential correlation with the clinical characteristics of PsA... - Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritisJuan D Canete
Institut Clínic de l Aparell Locomotor, and Unitat d Artritis, Servei de Reumatologia, Hospital Clinic de Barcelona, Villaroel 170, 08036 Barcelona, Spain
Arthritis Rheum 50:1636-41. 2004..Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to analyze the effects of infliximab on angiogenesis in the synovial membrane of patients with PsA who responded to this therapy... - Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritisMaría de Gracia Villa
Instituto de Microelectronica de Barcelona, IMB CNM CSIC, Campus UAB, Bellaterra, Barcelona, Spain
Biosens Bioelectron 27:113-8. 2011..A comparative study was carried out using control serum from a blood donor, which demonstrated the selectivity of the immunosensor response and its sensitivity for the detection of anti-CFFCP1 antibodies present in RA patients... - FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followupJulio Ramirez
Department of Rheumatology, Arthritis Unit, Hospital Clinic, Barcelona, Spain
J Rheumatol 39:1035-41. 2012..Our objective was to assess the potential influence of functionally relevant FCGR2A/CD32A (H131R) and FCGR3A/CD16A (V158F) genetic polymorphisms on the EULAR response to tumor necrosis factor-α (TNF-α) blocker therapy in PsA... - [Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martin Mola
Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Espana
Reumatol Clin 7:30-44. 2011..Rituximab has been employed successfully for the treatment of Rheumatoid Arthritis (RA). However, its particular mechanism of action, as well as a lack of concrete guidelines for its management have generated doubts on its use... - Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusionsAlfredo Adan
Department of Ophthalmology, Hospital Clinic de Barcelona, Universidad de Barcelona, Calle Sabino de Arana, 08036, Barcelona, Spain
Int Ophthalmol 30:577-81. 2010..Infliximab is an efficient long-term treatment for refractory posterior uveitis. Repeated infusions are required to maintain long-term remission which may be sustained on discontinuation of the drug... - Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patientsJosé Hernández Rodríguez
Vasculitis Research Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
Medicine (Baltimore) 86:233-41. 2007..Among them, the only patients who appear to be at low risk of developing ischemic events are those in whom a self-limiting episode of cranial symptoms can be recorded... - Successful treatment with infliximab in a patient with Diffuse Subretinal Fibrosis syndromeAlfredo Adan
Department of Ophthalmology, Hospital Clinic de Barcelona, Universidad de Barcelona, Barcelona, Spain
Am J Ophthalmol 143:533-4. 2007..To report a case of Diffuse Subretinal Fibrosis (DSF) syndrome refractory to immunosuppressive therapy who was successfully treated with anti-tumor necrosis factor-alpha (TNF)-alpha monoclonal antibodies infliximab... - Tobacco and other environmental risk factors in rheumatoid arthritisVirginia Ruiz-Esquide
Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
Reumatol Clin 8:342-50. 2012..In this article we review different environmental factors that have been associated with an increased risk of developing RA, with a special interest in tobacco smoking...